APA (7th ed.) Citation

D, B., JC, M., CM, N., R, M., P, W., M, K., . . . L, M. (2024). The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function - Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation. Biochimica et biophysica acta. Molecular basis of disease, 1870(2), 166978. https://doi.org/10.1016/j.bbadis.2023.166978

Chicago Style (17th ed.) Citation

D, Bull, Matte JC, Navarron CM, McIntyre R, Whiting P, Katan M, Ducotterd F, and Magno L. "The Hypermorphic PLCγ2 S707Y Variant Dysregulates Microglial Cell Function - Insight into PLCγ2 Activation in Brain Health and Disease, and Opportunities for Therapeutic Modulation." Biochimica Et Biophysica Acta. Molecular Basis of Disease 1870, no. 2 (2024): 166978. https://doi.org/10.1016/j.bbadis.2023.166978.

MLA (9th ed.) Citation

D, Bull, et al. "The Hypermorphic PLCγ2 S707Y Variant Dysregulates Microglial Cell Function - Insight into PLCγ2 Activation in Brain Health and Disease, and Opportunities for Therapeutic Modulation." Biochimica Et Biophysica Acta. Molecular Basis of Disease, vol. 1870, no. 2, 2024, p. 166978, https://doi.org/10.1016/j.bbadis.2023.166978.